Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.
Ming SunYingying CaoReona OkadaJeyshka M Reyes-GonzálezHannah G StackHaiying QinNan LiCharlie SeibertMichael C KellyFiorella SchischlikMitchell HoCarol J ThieleRosa NguyenPublished in: Journal for immunotherapy of cancer (2023)
Given the robust preclinical activity of CT3.28H.BBζ, these results form a promising basis for further clinical testing in children with NB.